Nanotechnology-Based Medical Devices for the Treatment of Chronic Skin Lesions: From Research to the Clinic

Clicks: 369
ID: 113178
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #14 of 55 articles by views in Pharmaceutics

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Chronic wounds, such as pressure ulcers, diabetic ulcers, venous ulcers and arterial insufficiency ulcers, are lesions that fail to proceed through the normal healing process within a period of 12 weeks. The treatment of skin chronic wounds still represents a great challenge. Wound medical devices (MDs) range from conventional and advanced dressings, up to skin grafts, but none of these are generally recognized as a gold standard. Based on recent developments, this paper reviews nanotechnology-based medical devices intended as skin substitutes. In particular, nanofibrous scaffolds are promising platforms for wound healing, especially due to their similarity to the extracellular matrix (ECM) and their capability to promote cell adhesion and proliferation, and to restore skin integrity, when grafted into the wound site. Nanotechnology-based scaffolds are emphasized here. The discussion will be focused on the definition of critical quality attributes (chemical and physical characterization, stability, particle size, surface properties, release of nanoparticles from MDs, sterility and apyrogenicity), the preclinical evaluation (biocompatibility testing, alternative in vitro tests for irritation and sensitization, wound healing test and animal wound models), the clinical evaluation and the CE (European Conformity) marking of nanotechnology-based MDs.
Reference Key
ruggeri2020pharmaceuticsnanotechnology-based Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Marco Ruggeri;Eleonora Bianchi;Silvia Rossi;Barbara Vigani;Maria Cristina Bonferoni;Carla Caramella;Giuseppina Sandri;Franca Ferrari;Ruggeri, Marco;Bianchi, Eleonora;Rossi, Silvia;Vigani, Barbara;Bonferoni, Maria Cristina;Caramella, Carla;Sandri, Giuseppina;Ferrari, Franca;
Journal Pharmaceutics
Year 2020
DOI
10.3390/pharmaceutics12090815
URL
https://doi.org/10.3390/pharmaceutics12090815
Keywords
biocompatibility medical devices critical quality attributes chronic wounds ce marking nanotechnologies wound models clinical evaluation

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.